Antigen Delivery with Poly(Propylacrylic Acid) Conjugation Enhances MHC-1 Presentation and T-Cell Activation
- 6 January 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 20 (2), 241-248
- https://doi.org/10.1021/bc800317a
Abstract
While many infectious diseases are controlled by vaccine strategies, important limitations continue to motivate the development of better antigen delivery systems. This study focuses on the use of a pH-sensitive polymeric carrier based on poly(propylacrylic acid) (PPAA) to address the need for more potent CD8 cytotoxic T-cell (CTL) responses. An MHC-1/CD8 CTL cell model system with ovalbumin as the protein antigen was used to test whether PPAA could enhance the delivery of ovalbumin into the MHC-1 display pathway. Ovalbumin was conjugated to poly(propylacrylic acid-co-pyridyldisulfide acrylate) (PPAA-PDSA) by disulfide exchange to make reversible conjugates that could be reduced by the glutathione redox system in the cytosol of antigen presenting cells. The PPAA-PDSA ovalbumin conjugates displayed the pH-sensitive membrane disruptive properties of the parent polymer as determined by their hemolysis activities (sharply active at the endosomal pH values of 6−6.5). The polymer−ovalbumin conjugates exhibited strong 22-fold increases in the MHC-1 presentation and ovalbumin-specific CTL activation compared to free ovalbumin. No CTL activation was observed with control conjugates of ovalbumin and poly(methylacrylic acid) (PMAA) that do not display membrane disruptive activies, suggesting that it is the membrane destabilizing properties of the polymer that result in increased MHC-1 display and CTL activation. Further mechanistic studies quantitated the time course of stable intracellular localization of radiolabeled conjugates. 52% of initially internalized PPAA-conjugated ovalbumin remained in the cells after 4 h, compared to less than 10% of ovalbumin or PMAA−ovalbumin. These results showing enhanced cytosolic delivery and MHC-1 presentation for the PPAA−antigen conjugates suggest that they warrant future characterization as a CD8-enhancing vaccine delivery system.Keywords
This publication has 53 references indexed in Scilit:
- Design, Synthesis, and Characterization of pH-Sensitive PEG−PE Conjugates for Stimuli-Sensitive Pharmaceutical Nanocarriers: The Effect of Substitutes at the Hydrazone Linkage on the pH Stability of PEG−PE ConjugatesBioconjugate Chemistry, 2007
- Targeting antigens to dendritic cells in vivoImmunobiology, 2006
- Topography of the Hydrophilic Helices of Membrane-Inserted Diphtheria Toxin T Domain: TH1−TH3 as a Hydrophilic TetherBiochemistry, 2006
- Polyketal Nanoparticles: A New pH-Sensitive Biodegradable Drug Delivery VehicleBioconjugate Chemistry, 2005
- Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumorJournal of Controlled Release, 2005
- A TAT–streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells"Protein Engineering, Design and Selection", 2005
- Polymeric micelles for delivery of poorly soluble drugs: Preparation and anticancer activityin vitroof paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipidsJournal of Drug Targeting, 2005
- pH-sensitive toxins: interactions with membrane bilayers and application to drug deliveryAdvanced Drug Delivery Reviews, 2004
- Enhanced Delivery of Exogenous Peptides into the Class I Antigen Processing and Presentation PathwayInfection and Immunity, 2002
- Introduction of soluble protein into the class I pathway of antigen processing and presentationCell, 1988